v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (42,780) $ (89,970)
Adjustments to reconcile net loss to net cash from operating activities    
Depreciation, amortization, and impairment 39,938 64,243
Inventory reserve expenses 13,941 27,776
Amortization of operating lease assets, debt costs, and other assets 3,332 3,959
Provision for expected credit losses 4,833 2,466
Deferred income taxes 924 333
Share-based compensation expense 21,012 21,474
Loss on disposal of fixed assets 521 861
Change in valuation of investment securities (16) (41)
Change in fair value of contingent consideration 3,014 (1,800)
Other 713 1,127
Changes in operating assets and liabilities    
Accounts receivable (1,292) 3,131
Inventories (32,908) (9,469)
Prepaid expenses and other current assets 1,766 797
Accounts payable (3,316) (5,656)
Other current liabilities (31,178) (9,052)
Contingent consideration milestone payment (2,864) (1,340)
Other long-term assets and liabilities 889 (3,189)
Net cash used in operating activities (23,471) 5,650
Cash flows from investing activities    
Capital expenditures (37,810) (23,749)
Other investing activities 146 22
Net cash used in investing activities (37,664) (23,727)
Cash flows from financing activities    
Proceeds from issuance of common shares 2,626 3,090
Payments related to tax withholdings for share-based compensation (150) (168)
Payments related to finance lease obligation (79) (564)
Borrowings under credit facility 64,025  
Contingent consideration milestone payment (3,170) (4,990)
Payment of debt issuance costs and other financing activities (24) (531)
Net cash provided by (used in) financing activities 63,228 (3,163)
Effect of exchange rate changes on cash (288) 1,448
Net change in cash, cash equivalents, and restricted cash 1,805 (19,792)
Cash, cash equivalents, and restricted cash at the beginning of period 85,115 85,738
Cash, cash equivalents, and restricted cash at the end of period 86,920 65,946
Components of cash, cash equivalents, and restricted cash at the end of period    
Cash and cash equivalents 86,322 62,860
Restricted cash 598 3,086
Cash, cash equivalents, and restricted cash at the end of period 86,920 65,946
Noncash investing activities - Accrued purchases of capital expenditures $ 16,096 12,923
Noncash investing activities - Purchase of intangible assets   $ 40